Update on intestinal strictures

Smyth R.L. , Van Velzen D. , Smyth A.R. , Lloyd D.A. , Heaf D.P. Strictures of ascending colon in cystic fibrosis and high strength pancreatic enzymes. Lancet 1994; 343: 85–6.

Van Velzen D. Colonic strictures in children with cystic fibrosis on low strength pancreatic enzymes. Lancet 1995; 346: 499–500.

Pawel B.R. , de Chadarevian J-P , Franco M.E. Pathology of fibrosing colonopathy of cystic fibrosis: a study of 12 cases and review of the literature. Hum Pathol 1997; 28: 395–9.

Littlewood J.M. , Hind C.R.K. eds. Fibrosing Colonopathy. Postgrad Med J 1994; 72(Suppl. 2): S1–62.

Jones R. , Franklin K. , Spicer R. , Berry J. Colonic strictures in children with cystic fibrosis on low strength pancreatic enzymes. Lancet 1995; 346: 499.

Nelson R. Personal communication, 1997.

Freiman J.P. , FitzSimmons S.C. Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States. J Pediatr Gastroenterol Nutr 1996; 22: 153–6.

FitzSimmons S.C. , Burkhart G.A. , Borowitz D. High dose pancreatic enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997; 336: 1283–9.

Hasler W.L. Pancreatic enzymes and colonic strictures with cystic fibrosis: a case-controlled study. Selected summaries. Gastroenterology 1988; 114: 609–11.

FitzSimmons S.C. , Lowenfels A.B. Pancreatic enzymes and colonic strictures with cystic fibrosis: a case-controlled study. Reply to comments. Gastroenterology 1998; 114: 611–12.

Reichard K.W. , Vinocur C.D. , Franco M. Fibrosing colonopathy in children with cystic fibrosis. J Pediatr Surg 1997; 32: 237–41.

Stevens J.C. , Maguiness K.M. , Hollingsworth J. , Heilman D.K. , Chong S.K. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. J Pediatr Gastroenterol Nutr 1998; 26: 80–4.

Stevens J.C. Unpublished observations.

Hausier M. , Mellicke R. , Riesterfeld S. , Heimann G. First adult patient with fibrosing colonopathy. Am J Gastroenterol 1998; 93: 1171–2.

Knabe N. , Zak M. , Hansen A. Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994; 343: 1230.

Pettei M.J. , Leonidas J.C. , Le vine J.J. , Gorvoy J.D. Pancolonic disease in cystic fibrosis and high doses enzyme therapy. J Pediatr 1994; 125: 587–9.

Schwarzenberg S.J. , Wielinski C.L. , Shamieh I. Cystic fibrosis-associated colitis and fibrosing colonopathy. J Pediatr 1995; 127: 565–70.

King S.J. , Van Velzen D. , Smyth R.L. , Carty H. , Heaf D. Strictures of the colon in cystic fibrosis. Clin Radiol 1994; 49: 476–7.

Crisci K.L. , Greenberg S.B. , Wolfson B.J. , Geller E. , Vinocur C.D. Contrast enema findings of fibrosing colonopathy. Pediatr Radiol 1997; 27: 315–16.

Zerin J.M. , Kuhn-Fulton J. , White S. Colonic strictures in children with cystic fibrosis. Radiology 1995; 194: 223–6.

Taylor C.J. Case reports. Postgrad Med J 1996; 72(Suppl. 2): S28–9.

O'Keefe P. Case reports. Postgrad Med J 1996; 72(Suppl. 2): S23–5.

Heaf D. Case reports. Postgrad Med J 1996; 72(Suppl. 2): S15–16.

Mahony M. Case reports. Postgrad Med J 1996; 72(Suppl. 2): S20–1.

Green M.R. , Southern K.W. , Wolfe S.P. , Littlewood J.M. , Najmaldin A.S. , Wyatt J.I. Colonic strictures in cystic fibrosis. Arch Dis Child 1995; 71: 191.

Waters B.L. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes. Pediatr Dev Pathol 1998; 1: 74–8.

Forstner G. , Gall G. , Corey M. Digestion and absorption of nutrients in cystic fibrosis. In: Sturgess, JM, ed. Proceedings of the 8th International Cystic Fibrosis Congress, 1980: 137–4–8.

Di Magno E.P. , Malagelada J.R. , Go V.L.W. , Moertel C.G. Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two dosage schedules. N Engl J Med 1977; 296: 1318–22.

Gow R. , Bradbear R. , Francis P. , Shepherd R. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: effectiveness of an enteric-coated preparation with and without antacids and cimetidine. Lancet 1981; ii: 1071–4.

Beverley D.W. , Kelleher J. , Littlewood J.M. , Robinson T. , Walters M.P. Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 1987; 62: 564–8.

Stead R.J. , Skypala I. , Hodson M.E. , Batten J.C. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis; comparison with a standard enteric-coated preparation. Thorax 1987; 42: 533–7.

Littlewood J.M. , Wolfe S.P. Nutrition in Cystic Fibrosis. In: Heatley R.V. , Green J.H. , Losowsky M.S. , eds. Consensus in Clinical Nutrition. Cambridge: Cambridge University Press, 1994: 388–419.

Morrison G. , Morrison J.M. , Redmond A.O.B. Comparison between standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Aliment Pharmacol Ther 1992; 6: 549–55.

Bowler I.M. , Wolfe S.P. , Owens H.M. , Sheldon T.A. , Littlewood J.M. , Walters M.P. A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis. Arch Dis Child 1993; 68: 227–30.

Shah A. , Dinwiddie R. , Madge S. , Prescott P. , Hudson G. High dose Nutrizym 22 in cystic fibrosis. Eur J Pediatr 1993; 152: 763–4.

Friesen C. , Prestidge C. Comparison of a high strength pancreatic enzyme preparation in cystic fibrosis. Adv Ther 1995; 12: 236–44.

Smyth R.L. , Ashby D. , O'Hea U. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995; 346: 1247–51.

Borowitz DS, Grand RJ, Durie PR, and the CFF Consensus Committee. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. J Pediatr 1995; 127: 681–4.

Bakowski M.T. , Prescott P. Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: implications for pathogenesis. Pharmacoepidemiology and Drug Safety 1997; 6: 347–58.

Littlewood J.M. Implications of the Committee on Safety of Medicines 10000 IU lipase/kg/day recommendation for use of pancreatic enzymes in cystic fibrosis. Arch Dis Child 1996; 74: 466–8.

Lowden J. , Goodchild M.C. , Ryley H.C. , Doull I.J.M. Maintenance of growth in cystic fibrosis despite reduction in pancreatic enzyme supplementation. Arch Dis Child 1998; 78: 377–8.

Van Velzen D. , Ball L.M. , Dezfulian A.R. , Southgate A. , Howard C.V. Comparative and experimental pathology of fibrosing colonopathy. Postgrad Med J 1996; 72(Suppl. 2): S39–48.

Ghanayem B.I. , Maronpot R.R. , Matthews H.B. Ethyl acrylate-induced gastric toxicity. III. Development and recovery of lesions. Toxicol Appl Pharmacol 1986; 83: 536–83.

Ball L.M. , Lannon C.L. , Van Velzen D. Long segment fusiform stenosis and colonic shortening equivelent to fibrosing colonopathy in the colon of adolescent pigs exposed to sodium lauryl sulphate and polysorbate 80. A chronic toxicity study. Pediatr Pulmonol 1997; 23(Suppl. 14): 310, 380.

Lannon C.L. , Hinchcliffe S.A. , Pope J.D. , Ball L.M. , Van Velzen D. Ulceration of the small and large bowel mucosa in resection specimens of cystic fibrosis patients with fibrosing colonopathy. International Journal of Toxicology 1998; 18: 77–99.

Dalzell A.M. , Freestone N.S. , Billington D. , Heaf D.P. Small intestinal permeability and oro-caecal transit time in cystic fibrosis. Arch Dis Child 1990; 65: 585–8.

Hughes D.M. , Pianosi P. , Van Velzen D. Pathology review of whole small and large bowel post mortem specimens in a paediatric population not exposed to methacrylic acid co-polymer coating before and after the emergence of fibrosing colonopathy. Pediatr Pulmonol 1997; 23(Suppl. 14): 313, 394.

Seal S. , McClean P. , Walters M. Stable isotope studies of pancreatic enzyme release in vivo. Postgrad Med J 1996; a, 72(Suppl. 2): S37–8.

Guarner L. , Rodriquez R. , Guarner F. , Malagada J-R. Fate of oral enzymes in pancreatic insufficiency. Gut 1993; 34: 708–12.

MacSweeney E.J. , Oades P.J. , Buchdal R. , Rosenthal M. , Bush A. Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis. Lancet 1995; 345: 752–6.

Oades P.J. , Rosenthal M. , MacSweeney E.J. , Bush A. Subclinical colonic thickening. J R Soc Med 1996; 89(Suppl. 27): 24–30.

Ramsden W.H. , Littlewood J.M. , Moya E.F. Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis. Arch Dis Child 1998; 79: 339–43.

Haigh L.I.G. , Morton A. , Conway S.P. An assessment of the relationship between colonic wall thickness obtained from ultrasound scans and the consumption of lipase and polymer in adult patients with cystic fibrosis. Davos: 21st European Cystic Fibrosis Conference, 1997: Poster P66.

Lucas J. , Atchley J. , Rolles C.J. , Fairhurst J. , Connett G.J. Colonic wall thickening is related to age and not the use of high strength pancreatin preparation in cystic fibrosis. Isr J Med Sci 1996; 32(Suppl.): S238.

Pohl M. , Krackhardt B. , Posselt H.G. , Lembcke B. Ultrasound studies of the intestinal wall in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1997; 25: 317–20.

Haber H.P. , Benda N. , Fitzke G. Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls. Gut 1997; 40: 406–11.

Pickhardt P.J. , Yagan N. , Siegel M.J. , Batre D.M. , Rothbaum R.J. Cystic fibrosis: CT findings of colonic disease. Radiology 1998; 206: 725–30.

Littlewood J.M. Management of malabsorption in cystic fibrosis: influence of recent developments on clinical practice. Postgrad Med J 1996; 72(Suppl. 2): S56–62.

Walters M.P. , Kelleher J. , Littlewood J.M. Clinical monitoring of steatorrhoea in cystic fibrosis. Arch Dis Child 1990; 63: 99–102.

Soldan W. , Henker J. , Sprossig C.H. Sensitivity and specificity of quantitative determination of pancreatic elastase 1 in faeces of children. J Pediatr Gastroenterol Nutr 1997; 24: 53–5.

Cade A. , Littlewood J.M. , Walters K.G. , Brownlee K.G. , Conway S.P. Faecal pancreatic elastase 1: experience of present use in a regional paediatric CF centre. Pediatr Pulmonol 1998; 26(Suppl. 17): 364.

Smyth R.L. Fibrosing colonopathy in cystic fibrosis. Arch Dis Child 1996; 74: 464–8.

Pounder R.E. Pancreatic enzyme supplements and fibrosing colonopathy. In: Aronson J.K. , ed. Side Effects of Drugs Annual 20. Elsevier, 1997: 322.

Croft N.M. , Marshall T.G. , Ferguson A. Gut inflammation in children in cystic fibrosis on high-dose enzyme supplements. Lancet 1995; 346: 1265–7.

Lee J. , Ip W. , Durie P. Is fibrosing colonopathy an immune mediated disease? Arch Dis Child 1997; 77: 66–70.